244260-84-2

Upstream product

• 186581-53-3 diazomethane 
• 244260-83-1 (2RS,1'S,2'E) 2-(4-methoxybenzyloxy)hex-5-enoic acid 4'-(tert-butyl(diphenyl)silyloxy)-1'-methylbut-2'-enyl ester 

Downstream Products

• 244260-91-1 2,2-Dimethyl-propionic acid (3aR,4R,5S,7aS)-4-(tert-butyl-diphenyl-silanyloxymethyl)-5-(4-methoxy-benzyloxy)-2,2-dimethyl-hexahydro-benzo[1,3]dioxol-5-ylmethyl ester 
• 244260-89-7 2,2-Dimethyl-propionic acid (1S,2R,3R,4S)-2-(tert-butyl-diphenyl-silanyloxymethyl)-3,4-dihydroxy-1-(4-methoxy-benzyloxy)-cyclohexylmethyl ester 
• 244260-88-6 2,2-Dimethyl-propionic acid (1S,2S)-2-(tert-butyl-diphenyl-silanyloxymethyl)-1-(4-methoxy-benzyloxy)-cyclohex-3-enylmethyl ester 
• 244260-87-5 [(1S,2S)-2-(tert-Butyl-diphenyl-silanyloxymethyl)-1-(4-methoxy-benzyloxy)-cyclohex-3-enyl]-methanol 
• 244260-85-3 (1S,2S) methyl 2-([tert-butyl(diphenyl)silyloxy]methyl)-1-(4-methoxybenzyloxy)cyclohex-3-ene-1-carboxylate 

Relevant academic research and scientific papers

A novel stereoselective route to a fumagillin and ovalicin synthetic intermediate

A strategy using a highly stereoselective Claisen-Ireland rearrangement followed by a Grubbs metathesis afforded in a good overall yield after further functionalisation a potentially synthetic precursor of fumagillin and ovalicin.